semaglutide gastric stasis attorney in kentucky glp-1 lawyer Kentucky lawyer climbed out of alcoholism, launched a recovery boom • Kentucky Lantern-mvanhaasteren.nl kentucky glp-1 gastric stasis law

Description

Many patients wonder if they can stay on a lower semaglutide dose after reaching their weight loss goal

Weight loss goals are now disease-driven, not cosmetic 5% minimum meaningful benefit 10% required for most metabolic conditions 15% often needed for OSA, HFpEF, MASH, and severe obesity Medication choice is guided by comorbidities GLP-1 receptor agonists and dual GIP/GLP-1 agents are prioritized in patients with: Prediabetes & type 2 diabetes ASCVD Heart failure with preserved EF Metabolic liver disease Obstructive sleep apnea Cardiovascular outcomes now matter Semaglutide 2.4 mg demonstrated a significant reduction in major cardiovascular events even in people without diabetes